Testing effectiveness (Phase 2)Study completedNCT02402998
What this trial is testing
Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
Who this might be right for
Primacy Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 55